Patent Assignment
Reel/Frame 044309/0728
Change of Name
Recorded: 2017-10-27
Pages: 3
Assignor
SYNTONIX PHARMACEUTICALS, INC.
Executed: 2010-05-19
Assignee
BIOGEN IDEC HEMOPHILIA INC.
9 FOURTH AVENUE, WALTHAM, MASSACHUSETTS, 02451
Covered Property
(1)
Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia
Application:
14/334,396 →
Publication:
US 2015/0044207
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Apr 30, 2015
From: BIOGEN IDEC HEMOPHILIA INC.
To: BIOGEN HEMOPHILIA INC.
Reel/Frame 035553/0325 →
Change of Address
Jul 2, 2015
From: BIOGEN HEMOPHILIA INC.
To: BIOGEN HEMOPHILIA INC.
Reel/Frame 036051/0773 →
Change of Name
Feb 16, 2017
From: BIOGEN HEMOPHILIA INC.
To: BIOVERATIV THERAPEUTICS INC.
Reel/Frame 041735/0662 →
Assignment of Assignor's Interest
Oct 27, 2017
From: RIVERA, DANIEL S.; PETERS, ROBERT T.; BITONTI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 043972/0790 →